Advertisement

Topics

Alfa Laval Company Profile

02:55 EDT 21st June 2018 | BioPortfolio

Alfa Laval is a leading global provider of specialized products and engineered solutions. Our equipment, systems and services are dedicated to helping customers to optimize the performance of their processes. Time and time again. We help our customers to heat, cool, separate and transport products such as oil, water, chemicals, beverages, foodstuffs, starch and pharmaceuticals. Our worldwide organization works closely with customers in almost 100 countries to help them stay ahead.Learn more about the Alfa Laval Group and our objectives by clicking on “Group Presentation” in the menu on the right. Here, you will also find information about our organization, history, the Alfa Laval brand, etc.
Latest news
Keep yourself updated on Alfa Laval! Under the headline Updates you will find the latest news about interesting orders we have obtained, new products, strategic alliances, Alfa Laval in media, etc., etc. Make it a habit to visit Updates, and you will be truly updated on Alfa Laval.

Contact

Phone: 46 46 36 72 31
Email: peter.torstensson@alfalaval.com


News Articles [125 Associated News Articles listed on BioPortfolio]

Alfa Laval UltraPure pumps meet the needs of most demanding pharmaceutical applications

Alfa Laval UltraPure pumps are specifically designed for the toughest, most demanding pharmaceutical applications. From high-value, high-risk productions, where every second counts, to reliability and...

Alfa Laval Wins SEK 70 Million Offshore Order

"I am very pleased to announce yet another large offshore order for our Framo pumping systems," says Peter Leifland, President of the Marine Division. "The Read more...

Alfa Laval has Signed an Agreement to Sell Parts of the Greenhouse Business to NIBE

The heat exchanger systems business has been a part of Greenhouse since 2016. It was moved there, along with a few other selected product groups, Read more...

FDA Approves Retacrit (epoetin alfa-epbx) as First Epoetin Alfa Biosimilar for the Treatment of Anemia

May 15, 2018 -- The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney ...

Pfizer: FDA Oks First Epoetin Alfa Biosimilar For Treatment Of Anemia

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) announced the United States Food and Drug Administration approved Retacrit orepoetin alfa-epbx, a biosimilar to Epogen and Procrit (epoetin alfa), for a...

FDA Approves Pfizer’s Retacrit, the First Epoetin Alfa Biosimilar for the Treatment of Anemia

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) today announced the United States (U.S.) Food and Drug Administration (FDA) approved RETACRIT® (epoetin alfa-epbx), a biosimilar to Epogen...

FDA approves Pfizer’s epoetin alfa biosimilar Retacrit

FDA Approves Epoetin Alfa Biosimilar for Anemia

The FDA has approved epoetin alfa-epbx (Retacrit) as a biosimilar to epoetin alfa (Epogen/Procrit) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in p...

Drugs and Medications [117 Associated Drugs and Medications listed on BioPortfolio]

Ribavirin [Aurobindo Pharma Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin tablets. Ribavirin Tablets Initial U.S. Approval: 200...

Ribavirin [Sandoz Inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. Ribavirin Tablets, oralInitial U.S. ...

Ribavirin [Zydus Pharmaceuticals (USA) Inc.]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

Ribavirin [Cadila Healthcare Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

Ribasphere ribapak [Three Rivers Pharmaceuticals, LLC]

These highlights do not include all the information needed to use Ribasphere (ribavirin, USP) safely and effectively. See full prescribing information for Ribasphere (ribavirin, USP). Ribasphere (riba...

PubMed Articles [31 Associated PubMed Articles listed on BioPortfolio]

A strategy to reduce inflammation and anemia treatment's related costs in dialysis patients.

This is a post-hoc analysis evaluating erythropoiesis stimulating agents' (ESA) related costs while using an additional ultrafilter (Estorclean PLUS) to produce ultrapure dialysis water located within...

Changes in in vivo confocal microscopic findings of ocular surface squamous neoplasia during treatment with topical interferon alfa-2b.

To evaluate in vivo confocal microscopy (IVCM) findings of ocular surface squamous neoplasia (OSSN) during treatment with topical interferon alfa-2b (IFN alfa-2b).

Immune tolerance induction rescue with turoctocog-alfa in a poor risk haemophilia A inhibitor young child: the history of a success.

: The development of alloantibodies against the replacement of Factor VIII (FVIII) is the major complication in haemophilia A treatment. The gold standard to eradicate inhibitors is the immune toleran...

Andexanet alfa effectively reverses edoxaban anticoagulation effects and associated bleeding in a rabbit acute hemorrhage model.

Increasing use of factor Xa (FXa) inhibitors necessitates effective reversal agents to manage bleeding. Andexanet alfa, a novel modified recombinant human FXa, rapidly reverses the anticoagulation eff...

Thrombomodulin alfa attenuates the procoagulant effect and cytotoxicity of extracellular histones through the promotion of protein C activation.

Extracellular histones are reported to increase thrombin generation in the plasma and induce endothelial cell death in vitro. These effects of histones were suggested to involve histone-induced inhibi...

Clinical Trials [904 Associated Clinical Trials listed on BioPortfolio]

Study Comparing Reduction and Viral Safety of IFN Alfa-2b XL + Ribavirin Versus PEG IFN Alfa-2b + Ribavirin in Patients With Chronic Hepatitis C Genotype 1

The purpose of this study is to confirm if IFN alfa-2b XL has a better antiviral activity and tolerability as compared with current marketed reference, while combined with ribavirin, in a ...

Cost-effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have Anemia

The purpose of this study is to evaluate the cost-effectiveness of epoetin alfa compared with darbepoetin alfa in the treatment of anemia in adults receiving chemotherapy for cancer. Epoe...

PROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD Patients

The purpose of this study is to demonstrate that once every-2-weeks and once every-4-weeks treatment with epoetin alfa, a drug that increases red blood cell production, in patients with an...

Corifollitropin Alfa Combined With Menotropin Versus Follitropin and Lutropin Alfa in Expected Suboptimal Responders

In an opened randomized study of women undergoing in vitro fertilization with expected suboptimal response to controlled ovarian stimulation (Poseidon Group 2b) investigators will examine ...

Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy

RATIONALE: Epoetin alfa and darbepoetin alfa may cause the body to make more red blood cells. They are used to treat anemia caused by chemotherapy in patients with cancer. PURPOSE: This r...

Companies [36 Associated Companies listed on BioPortfolio]

Alfa Laval

Alfa Laval is a leading global provider of specialized products and engineered solutions. Our equipment, systems and services are dedicated to helping customers to optimize the performance of their pr...

Laval Lab

Laval Lab was founded in 1982.With its strong customer-oriented approach, Laval Lab commands attention as a central resource for advice regarding appropriate scientific instruments.Product Catalogue -...

Alfa Scientific Designs, Inc.

Alfa Scientific Designs, Inc. is a leader in the development and manufacture of rapid, immunoassay, point-of-care tests. As a minority, woman-owned, small business, ALFA offers a ...

Assisted Living Federation of America (ALFA)

The Assisted Living Federation of America (ALFA) is the largest national association exclusively dedicated to professionally managed assisted living communities and the seniors an...

Assisted Living Federation of America

The Assisted Living Federation of America (ALFA) is the largest national association exclusively dedicated to professionally managed assisted living communities and the seniors and families they serve...

More Information about "Alfa Laval" on BioPortfolio

We have published hundreds of Alfa Laval news stories on BioPortfolio along with dozens of Alfa Laval Clinical Trials and PubMed Articles about Alfa Laval for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alfa Laval Companies in our database. You can also find out about relevant Alfa Laval Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record